Chat with us, powered by LiveChat

Settlement Reached with Takeda for $2.4 Billion for Actos Bladder Cancer Litigation

April 29, 2015
Home Firm News Settlement Reached with Takeda for $2.4 Billion for Actos Bladder Cancer Litigation

Weitz & Luxenberg’s Paul Pennock was one of two court-appointed lead counsel on the Plaintiffs Steering Committee for the multidistrict litigation against drug manufacturer Takeda. The litigation was for the diabetes drug Actos, which may cause bladder cancer.  Read more in The Wall Street Journal article, Takeda Pharmaceutical to Pay up to $2.4 Billion to Settle U.S. Lawsuits.

Join Our Newsletter and Never Miss a Post

Request A Free Consultation

"*" indicates required fields

Disclaimer*
Disclaimer
Your consent to contact is not required. To proceed without providing consent,  please call us at (855) 930-5906.